Status:
UNKNOWN
Schistosomiasis Diagnosis Using a CAA Antigen Test
Lead Sponsor:
Centre de Recherche Médicale de Lambaréné
Collaborating Sponsors:
Universität Tübingen
Conditions:
Schistosomiasis Hematobium
Diagnostic
Eligibility:
FEMALE
Phase:
PHASE3
Brief Summary
Schistosomiasis is one of most important human parasitic diseases worldwide. Pregnant women and their infants are two vulnerable population groups, particularly in sub-Saharan Africa, where - amongst ...
Detailed Description
Study design The freeBILy-GAB study is a set of interlinked prospective, observational studies conducted in Gabon to comprehensively assess the performance of CAA measurement for the detection of S. ...
Eligibility Criteria
Inclusion
- Pregnant women with a gestational age comprised between 16 and 30 weeks (based on last date of menses)
- Willing to deliver in one of the four maternities: three in Lambaréné and one in Fougamou
- Provide a written informed consent for both themselves and for newborn follow-up or the written informed consent by the legal guardian if pregnant woman is a minor
Exclusion
- \- Willing to move out of the study area within the coming 24 months
- Known having a medically confirmed complicated pregnancy a complicated pregnancy.
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03779347
Start Date
May 1 2019
End Date
May 1 2022
Last Update
July 27 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de Recherches Médicales de Lambaréné
Lambaréné, Moyen-Ogooué Province, Gabon, BP 242
2
Centre de Recherches Medicales de Lambaréné
Lambaréné, Gabon